All Outputs (4)

Playing in the UEFA Europa League Does Not Adversely Affect English Premier League or La Liga Performance (2018)
Journal Article
Stephens, R., Bosworth, G., & Shepherd, T. A. (2018). Playing in the UEFA Europa League Does Not Adversely Affect English Premier League or La Liga Performance. Journal of Functional Morphology and Kinesiology, 4(1 (Special Issue Sport Psychology)), https://doi.org/10.3390/jfmk4010002

Purpose: This article presents data challenging the widely held but untested view that concurrently playing mid-week Union of European Football Associations (UEFA) Europa League matches adversely affects domestic league performance. Method: Over... Read More about Playing in the UEFA Europa League Does Not Adversely Affect English Premier League or La Liga Performance.

Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson’s disease without cognitive impairment (2017)
Journal Article
Shepherd, T. A., Edelstyn, N. M., Longshaw, L., Sim, J., Watts, K., Mayes, A. R., …Ellis, S. J. (2017). Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson’s disease without cognitive impairment. Pilot and Feasibility Studies, https://doi.org/10.1186/s40814-017-0154-7

BACKGROUND: The aim was to assess the feasibility of a single-centre, single-blind, randomized, crossover design to explore the effects of two slow-release dopamine agonists, ropinirole and pramipexole, on cued recall in Parkinson's disease. As the d... Read More about Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson’s disease without cognitive impairment.

Evidence of an amnesia-like cued-recall memory impairment in nondementing idiopathic Parkinson's disease. (2015)
Journal Article
Edelstyn, N. M., John, C. M., Shepherd, T. A., Drakeford, J. L., Clark-Carter, D., Ellis, S. J., & Mayes, A. R. (2015). Evidence of an amnesia-like cued-recall memory impairment in nondementing idiopathic Parkinson's disease. Cortex, 71, 85-101. https://doi.org/10.1016/j.cortex.2015.06.021

Medicated, non-dementing mild-to-moderate Parkinson's disease (PD) patients usually show recall/recollection impairments but have only occasionally shown familiarity impairments. We aimed to assess two explanations of this pattern of impairment. Reco... Read More about Evidence of an amnesia-like cued-recall memory impairment in nondementing idiopathic Parkinson's disease..

Effect of disease severity and dopaminergic medication on recollection and familiarity in patients with idiopathic nondementing Parkinson's. (2009)
Journal Article
Edelstyn, N., Shepherd, T. A., Mayes, A. R., Sherman, S. M., & Ellis, S. J. (2010). Effect of disease severity and dopaminergic medication on recollection and familiarity in patients with idiopathic nondementing Parkinson's. Neuropsychologia, 48(5), 931 -938. https://doi.org/10.1016/j.neuropsychologia.2009.12.039

The effect of disease severity and dopaminergic medication on the assessment of familiarity and the recollection of episodic details during recognition in nondementing idiopathic Parkinson's is uncertain. Some studies have reported familiarity as def... Read More about Effect of disease severity and dopaminergic medication on recollection and familiarity in patients with idiopathic nondementing Parkinson's..